@article{4ca8930d774943d0be6157929eb40b53,
title = "American association of clinical endocrinologists and American college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis - 2016",
abstract = "The American Association of Clinical Endocrinologists/American College of Endocrinology Medical Guidelines for Practice are systematically developed statements to assist healthcare professionals in medical decision-making for specific clinical conditions. Most of the content herein is based on literature reviews. In areas of uncertainty, professional judgment was applied. These guidelines are a working document that reflects the state of the field at the time of publication. Because rapid changes in this area are expected, periodic revisions are inevitable. We encourage medical professionals to use this information in conjunction with their best clinical judgment. The presented recommendations may not be appropriate in all situations. Any decision by practitioners to apply these guidelines must be made in light of local resources and individual patient circumstances.",
author = "Camacho, {Pauline M.} and Petak, {Steven M.} and Neil Binkley and Clarke, {Bart L.} and Harris, {Steven T.} and Hurley, {Daniel L.} and Michael Kleerekoper and Lewiecki, {E. Michael} and Miller, {Paul D.} and Narula, {Harmeet S.} and Rachel Pessah-Pollack and Vin Tangpricha and Wimalawansa, {Sunil J.} and Watts, {Nelson B.}",
note = "Funding Information: Dr. Pauline Camacho reports that she has received research grant support from Amgen Inc, and NPS Pharmaceuticals. Funding Information: sultant honoraria and research grant support from Amgen, Eli Lilly and Company, and Merck. Funding Information: fees for his role on Scientific Advisory Boards for Amgen, AgNovos, Eli Lilly and Company, Merck, Radius Pharma, Roche, and Ultragenyx, as well as for his role on Data Safety Committees for Allergan Pharmaceuticals, and GrĀ1/4nenthal Group. He has also received speaker honoraria from Amgen Australia and research grant support from Alexion, Amgen, Boehringer Ingelheim, Immunodiagnostics, Eli Lilly and Company, Merck, Merck Serrano, National Bone Health Alliance, Novartis, Radius Pharma, Roche Diagnostics, Regeneron, Daiichi Sankyo, and Ultragenyx. Funding Information: sulting fees from Elsevier, as the Editor in Chief for the Journal of Clinical and Translational Endocrinology. Dr. Tangpricha has also received speaker honoraria from Quest Diagnostics Inc and research grants from the Cystic Fibrosis Foundation and NIH.",
year = "2016",
doi = "10.4158/EP161435.GL",
language = "English (US)",
volume = "22",
pages = "1--42",
journal = "Endocrine Practice",
issn = "1530-891X",
publisher = "American Association of Clinical Endocrinology",
}